Covid Booster Jabs for all September 16, 2023 Unipro2013main News, World News </p> <h2>Booster Jabs for all</h2> <p> Updated COVID-19 vaccines are recommended for everyone 6 months and older and will be available by the end of this week<br /> ‘Safe and effective’<br /> Estimated hospitalizations prevented per 1,000,000 vaccine doses<br /> 12 -17 years<br /> 19-95 hospitalizations,<br /> 5-19 ICU admissions,<br /> and perhaps one death.</p> <p>5 – 11 years<br /> 16 hospitalizations,<br /> (based on Spring 2023 data)<br /> 18 – 49 years<br /> 75 hospitalizations,<br /> (based on Spring 2023 data)<br /> Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults</p> <p>https://pubmed.ncbi.nlm.nih.gov/36055…</p> <p>Pfizer vaccines excess risk of serious adverse events</p> <p>(Higher than placebo baseline)</p> <p>10.1 per 10,000</p> <p>101 per 100,000</p> <p>1,010 per 1,000,000</p> <p>Moderna vaccines excess risk of serious adverse events</p> <p>(Higher than placebo baseline)</p> <p>15.1 per 10,000</p> <p>151 per 100,000</p> <p>1,510 per 1,000,000</p> <p>In Western Australia</p> <p>https://www.health.wa.gov.au/~/media/…</p> <p>Total AEFI rate following a COVID-19 vaccine</p> <p>264.1 per 100,000 doses</p> <p>2,641 per 1,000,000 doses</p> <p>https://www.reuters.com/business/heal…</p> <p>March 22 Moderna chief executive defended the company’s plan to quadruple the price of its COVID-19 vaccine,</p> <p>$130 per dose</p> <p>Pfizer last year suggested $110 to $130 per dose.</p> <p>From FDA to MHRA: are drug regulators for hire?</p> <p>https://www.bmj.com/content/377/bmj.o…</p> <p>Money derived from Industry</p> <p>US Food and Drug Administration, $3,416,000,000 (2022)</p> <p>The revolving door</p> <p>FDA, nine out of 10 of its past commissioners, 2006 to 2019 went on to secure roles linked with pharmaceutical companies</p> <p>https://www.fda.gov/about-fda/fda-org…</p> <p>2005 UK, House of Commons’ health committee</p> <p>Industry funding could lead MHRA, to “lose sight of the need to protect and promote public health above all else as it seeks to win fee income from the companies.”</p> <p>BMJ investigation (2022)</p> <p>We found that industry money permeates the globe’s leading regulators,</p> <p>raising questions about their independence</p> <p>Sociologist Donald Light, Rowan University, New Jersey</p> <p>“Like the FDA, the TGA was founded to be an independent institute.</p> <p>However, being largely funded by fees from the companies whose products it is charged to evaluate is a fundamental conflict of interest,</p> <p>and a prime example of institutional corruption.”</p> <p>It is no longer possible for doctors and patients to receive unbiased, rigorous evaluations from drug regulators.</p> <p>FDA</p> <p>“It’s the opposite of having a trustworthy organisation independently and rigorously assessing medicines.</p> <p>They’re not rigorous, they’re not independent, they are selective, and they withhold data.</p> <p>Doctors and patients must appreciate how deeply and extensively drug regulators can’t be trusted so long as they are captured by industry funding.”</p> <p>Revisiting financial conflicts of interest in FDA advisory committees</p> <p>https://pubmed.ncbi.nlm.nih.gov/25199…</p> <p>Large study, FDA advisory committee members over 15 years,</p> <p>those with financial interests solely in the sponsoring firm were more likely to vote in favour of the sponsor’s product.<br /> Transcript<br /> <br /> Credit to : Dr. John Campbell</p> <p> Please support our Sponsors here :
